Home > Medical Services > Adult Congenital Heart Disease

Adult Congenital Heart Disease Treatment at Memorial Adult Congenital Heart Center

Until recently, South Florida adults with congenital heart disease have not had access to a comprehensive congenital heart center offering coordinated care focusing on their unique needs. The team members at Memorial Adult Congenital Heart Center are experts in congenital anomalies of the heart. Thanks to the extraordinary advances in cardiac surgery and noninvasive diagnosis during the past 50 years, more and more children with congenital heart disease have grown up, leading to a record population of adults with congenital heart disease and the complications that accompany it. Today, there are approximately 1 million adults with adult congenital heart disease (ACHD) in the United States and about 1 percent of the population is born with a congenital defect.

Memorial Adult Congenital Heart Center is a joint program of Memorial Cardiac and Vascular Institute and the Heart Institute at Joe DiMaggio Children's Hospital. The program's primary mission is to provide comprehensive, multidisciplinary care for the growing population of adults with ACHD. Our expert team is led by internationally renowned interventional cardiologist, Larry Latson, MD, Director of Pediatric & Congenital Interventional Cardiology & Medical Director of the Memorial Adult Congenital Cardiac Center. We continue to work closely with community cardiologists to offer comprehensive care to patients requiring adult congenital heart disease treatment.

In fact, the physicians at Memorial Adult Congenital Heart Center have pioneered many of the advances in congenital cardiology procedures including catheter treatment of an atrial septal defect (ASD), coarctation and ventricular septal defect (VSD). In addition to catheter techniques, our cardiac surgeons have been leaders in the advances in surgical procedures such as valve reconstruction, the Ross procedure, and valve replacement.

Clinical trials can play a crucial role in the ability to determine what new tests and therapies could improve adult congenital heart disease treatments options. Currently, several prospective randomized trials on closure of a patent foreman ovale (PFO) are under way for stroke prevention and for management of migraine. Clinical protocols are moving forward to evaluate valved conduits and cardioplegic solutions. Our team is also participating in trials for VSD, including post-infarction VSD closure, and patent ductus arteriosus (PDA) closure.

From evaluation and treatment of a simple PFO, to a complex adult with Tetralogy of Fallot or a complex single ventricle, the Memorial Adult Congenital Heart Program offers a Center of Excellence. For referral to the Memorial Adult Congenital Heart Disease Treatment Program, please call 954-265-ACHD (2243) or toll-free at 877-265-ACHD.